Basically through the documents and slide presentations published earlier here, we've now shown that AstraZeneca sales, marketing and training have a coordinated campaign to sell against letrozole.
WITHOUT ANY COMPARATIVE DATA.
The OIG has been notified and will have to determine if this violates AstraZeneca's policy, which by definition also would be a violation of AZ's Corporate Integrity Agreement.
For earlier coverage of this story, click links for CNBC television and print news media.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).